DJIA 18,232.02 -53.72 -0.29%
NASDAQ 5,089.36 -1.43 -0.03%
S&P 500 2,126.06 -4.76 -0.22%
market minute promo

MannKind Corp (NASDAQ: MNKD)



company name or ticker

Looking at Mannkind's Afrezza Sales Estimates Ahead of Sanofi Earnings

MannKind Looks Good For Long Term Investors

MannKind's Future: More than Just Afrezza?

MannKind's pipeline of opportunity is explored.

MannKind to Manufacture 12 Unit Cartridge Strength of AFREZZA(R) Following FDA Approval

MannKind Corporation: Past, Present, and Future

Let's learn about the history and future prospects of MannKind as it launches its first drug, Afrezza.

MannKind Corporation: A Good Risk/Reward Play For The Long Haul

10 Most Hated Companies in Healthcare

When emotional trading is on display, the short-sellers come out to play. Find out which companies are the most hated in healthcare, why they're so universally disliked, and which company may eventually deserve a reprieve.

Marketocracy Top 20 Manager, Nate Pile, Invested In MannKind And Afrezza

3 Questions to Ask Before You Buy a Biotech Stock

One Motley Fool analyst explains the key questions investors should answer before buying biotech stocks.

Pain-Free Blood Tests? Sign Me Up!

A small, Wisconsin-based company could be on the verge of developing a revolutionary new blood test that is virtually pain-free. Find out how personalized healthcare is transforming the medical field.
See More Articles...